NDLI: Multidisciplinary Management of Hepatocellular Carcinoma in Clinical Practice

Content Provider	PubMed Central
Author	Bruera, Gemma Cannita, Katia Giordano, Aldo Victor Manetta, Rosa Vicentini, Roberto Carducci, Sergio Saltarelli, Patrizia Nerio, Iapadre Coletti, Gino Corrado, Ficorella Enrico, Ricevuto
Copyright Year	2014
Abstract	Background. Hepatocellular carcinoma (HCC) patients require different treatment strategies according to disease extension, liver function, and patient's fitness. We evaluated HCC multidisciplinary management in clinical practice. Methods. Consecutive patients were followed and treated with tailored medical, locoregional, and surgical treatments, according to disease stage and patient's fitness (age, Cumulative Illness Rating Scale (CIRS)). Activity, efficacy, and safety were evaluated. Results. Thirty-eight patients were evaluated: median age, 74; elderly 92%; CIRS secondary 28 (74%); Child-Pugh A 20 (53%), B 11 (29%); and Barcelona Clinic Liver Cancer (BCLC) 0 2 (5%), A 9 (24%), B 10 (26%), C 13 (34%), and D 4 (11%). Overall survival (OS) was 30 months. At 9 months median follow-up, among 25 unresectable HCC, OS was 10 months; BCLC B–D unfit for sorafenib showed OS 3 months. Ten patients (40%) received sorafenib: Child-Pugh A 5 (50%) and B 5 (50%) and disease control rate 89%, progression-free survival 7 months, and OS 9 months. G3-4 toxicities: anorexia, hypertransaminaemia, hyperbilirubinemia, and hypercreatininemia. Limiting toxicity syndromes were 40%, all multiple sites. Conclusion. HCC patients require multidisciplinary clinical management to properly select tailored treatments according to disease stage, fitness, and liver function. Patients suitable for sorafenib should be carefully selected, monitored for individual safety, and prevalently characterized by limiting toxicity syndromes multiple sites.
Related Links	http://dx.doi.org/10.1155/2014/806391
Starting Page	806391
File Format	PDF
ISSN	23146141
e-ISSN	23146141
Journal	BioMed Research International
Volume Number	2014
Language	English
Publisher	Hindawi Publishing Corporation
Publisher Date	2014-01-01
Access Restriction	Open
Rights Holder	Hindawi Publishing Corporation
Subject Keyword	Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Immunology and Microbiology Medicine Biochemistry, Genetics and Molecular Biology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Progesterone and Related Compounds in Hepatocellular Carcinoma: Basic and Clinical Aspects

Inducible zebrafish model of hepatocellular carcinoma

Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma

Hepatocellular Carcinoma: Carcinogenesis, Establishment, Progression, and Therapies

Involvement of DNA Damage Response Pathways in Hepatocellular Carcinoma

Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies

MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target

Expression of Serum Exosomal MicroRNA-21 in Human Hepatocellular Carcinoma

The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma

Multidisciplinary Management of Hepatocellular Carcinoma in Clinical Practice

Similar Documents

Progesterone and Related Compounds in Hepatocellular Carcinoma: Basic and Clinical Aspects

Inducible zebrafish model of hepatocellular carcinoma

Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma

Hepatocellular Carcinoma: Carcinogenesis, Establishment, Progression, and Therapies

Involvement of DNA Damage Response Pathways in Hepatocellular Carcinoma

Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies

MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target

Expression of Serum Exosomal MicroRNA-21 in Human Hepatocellular Carcinoma

The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma

Multidisciplinary Management of Hepatocellular Carcinoma in Clinical Practice